Patients Jobs About Novo Nordisk Contact information Finland | Media Research and development Responsible business front page / Patients / Diabetes Patients Diabetes Type 1 diabetes Type 2 diabetes Gestational diabetes Daily self-care Hypoglycemia Hemophilia Growth hormone Menopause Products Injection equipment Diabetes Diabetes (formerly known as diabetes) is a common name for a group of diseases associated with long-term elevated blood sugar. The most commonly referred to is type 1 diabetes or type 2 diabetes, but in reality, these types represent two very different extremes of the disease. In addition to these main types, there are several intermediate and specific types of diabetes, the most common of which is gestational diabetes. Diabetes is a long-term illness that requires daily self-care. People with diabetes do not produce enough or no insulin at all, or the insulin does not work properly. Insulin is an essential hormone in the body that is used to transfer energy in the form of glucose from the blood to the cells of the body. The purpose of diabetes treatment is either to replace the missing insulin hormone in the body or, if there is still its own insulin production, to help the body lower its own blood sugar. Diabetes is one of the fastest growing diseases in Finland and in the world, although it is not a contagious disease. There are about 300,000 people diagnosed with diabetes in Finland, of whom about 50,000 suffer from type 1 and about 250,000 from type 2. In addition, it is estimated that almost 150,000 Finns suffer from type 2 diabetes or its precursor unknowingly. Assessment of risk factors for diabetes (eg by performing a diabetes risk test) and, if necessary, regular blood glucose monitoring is important, especially for the early detection of type 2 diabetes. Untreated diabetes leads to serious additional illnesses such as premature blindness, kidney damage, or heart attack. Additional diseases can be avoided with good treatment started well in advance. Who are we Tanskalainen Novo Nordisk on globaali lääkealan yritys, jolla on yli 90 vuoden kokemus edelläkävijänä diabeteshoidon kehittämisessä. Yritys on johtavassa asemassa myös hemofilian hoidon, kasvuhormonihoidon ja vaihdevuosien hormonihoidon kehittämisessä. Novo Nordiskilla on noin 41 400 työntekijää (kesäkuu 2017) 77 eri maassa, ja sen tuotteita markkinoidaan yli 165 maassa. Novo Nordisk A/S novonordisk.com Tai valitse : muut sivustot Novo Nordisk maailmalla Kartta ja osoitteet Facebook © Novo Nordisk A/S 2017 Vastuuvapaus ja yksityisyys